Hackensack Meridian Health’s Vanguard Morningstar Small-Cap Value ETF VBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-780,201
Closed -$124M 6
2023
Q3
$124M Sell
780,201
-372,403
-32% -$62.3M 18.47% 3
2023
Q2
$191M Buy
1,152,604
+1,983
+0.2% +$312K 26.17% 2
2023
Q1
$183M Buy
1,150,621
+2,132
+0.2% +$353K 26.42% 2
2022
Q4
$182M Buy
1,148,489
+2,557
+0.2% +$407K 25.64% 2
2022
Q3
$164M Buy
1,145,932
+1,956
+0.2% +$311K 22.45% 2
2022
Q2
$171M Sell
1,143,976
-285,000
-20% -$46.7M 19.06% 2
2022
Q1
$251M Hold
1,428,976
26.23% 1
2021
Q4
$256M Buy
+1,428,976
New +$254M 24.79% 1

Other funds holding VBR

Hackensack Meridian Health's VBR Position: Q4 2023 in Review

Hackensack Meridian Health sold out of Vanguard Morningstar Small-Cap Value ETF (VBR) in Q4 2023, closing a stake of 780,201 shares — an estimated $124M sold.

Hackensack Meridian Health first reported a position in VBR in Q4 2021 and held it in 8 quarters. The position peaked at $256M in Q4 2021. 1,384 funds tracked by Wall St. Rank hold VBR as of Q4 2023.

  • Hackensack Meridian Health reported no remaining Vanguard Morningstar Small-Cap Value ETF position as of Q4 2023 after selling out during the quarter.
  • Hackensack Meridian Health sold 780,201 Vanguard Morningstar Small-Cap Value ETF shares in Q4 2023, an estimated $124M.
  • Hackensack Meridian Health first reported a position in Vanguard Morningstar Small-Cap Value ETF in Q4 2021 and held it in 8 quarters.
  • Hackensack Meridian Health's Vanguard Morningstar Small-Cap Value ETF position peaked at $256M in Q4 2021.
  • 1,384 funds tracked by Wall St. Rank held Vanguard Morningstar Small-Cap Value ETF as of Q4 2023.

Based on Hackensack Meridian Health's 13F filing for Q4 2023, filed 8 Feb 2024.